metastatic breast cancer
Showing NaN - NaN of 36
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)
Not yet recruiting
- Metastatic Breast Cancer
- Fulvestrant plus AI plus ribociclib
- AI plus ribociclib
-
Seoul, Korea, Republic ofKorea university Guro hospital
Apr 16, 2023
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +4 more
-
West Hollywood, California
- +101 more
Jan 16, 2023
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +6 more
-
Iowa City, Iowa
- +60 more
Jan 3, 2023
Patterns and Associated Outcomes in HER2-positive Unresectable
Completed
- Metastatic Breast Cancer
- None (Observational study)
-
Macquarie, New South Wales, Australia
- +43 more
Nov 23, 2022
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab Emtansine, Atezolizumab, Placebo)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab Emtansine
- +2 more
-
Fountain Valley, California
- +139 more
Aug 17, 2022
Metastatic Breast Cancer Trial in Worldwide (Abemaciclib)
Available
- Metastatic Breast Cancer
-
Liverpool, New South Wales, Australia
- +229 more
Aug 17, 2022
Real-world Prescription Pattern of Palbociclib Combination
Active, not recruiting
- Metastatic Breast Cancer
- Patients who received Palbociclib as first line therapy in MBC setting
-
Seoul, Korea, Republic ofPfizer Local Country Office
Jun 28, 2022
Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate
Recruiting
- Metastatic Breast Cancer
- sacituzumab govitecan (IMMU-132)
- +4 more
-
Beijing, China
- +43 more
Apr 19, 2022
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer Trial in Korea, Republic of, United States (ZB716,
Recruiting
- Estrogen Receptor-Positive
- +3 more
-
Seattle, Washington
- +7 more
Mar 20, 2022
Metastatic Breast Cancer Trial in Seoul (Pembrolizumab)
Not yet recruiting
- Metastatic Breast Cancer
-
Seoul, Korea, Republic ofYonsei Cancer Center at Yonsei University Health System
Mar 14, 2022
Metastatic Breast Cancer Trial in Seoul (Durvalumab with Tremelimumab)
Completed
- Metastatic Breast Cancer
- Durvalumab with Tremelimumab
-
Seoul, Korea, Republic ofYonsei Cancer Center, Severance Hospital, Yonsei University Heal
Dec 30, 2021
Locally Advanced or, Metastatic Breast Cancer Trial in Korea, Republic of (Fulvestrant)
Completed
- Locally Advanced or
- Metastatic Breast Cancer
-
Cheongju-si, Korea, Republic of
- +8 more
Sep 3, 2021
Metastatic Breast Cancer Trial in Worldwide (PF-05280014, Paclitaxel, Herceptin®)
Completed
- Metastatic Breast Cancer
- PF-05280014
- +2 more
-
Plainville, Connecticut
- +187 more
Jun 7, 2021
Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))
Completed
- Locally Recurrent Breast Cancer
- Metastatic Breast Cancer
- NKTR-102
- Treatment of Physician's Choice (TPC)
-
Flagstaff, Arizona
- +152 more
May 6, 2021
HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)
Unknown status
- HER2-positive Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab biosimilars(Herzuma), Gedatolisib
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 16, 2021
Metastatic Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab emtansine, Placebo)
Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)
Unknown status
- Metastatic Breast Cancer
- Locally Recurrent Breast Cancer
-
Fresno, California
- +87 more
Nov 26, 2020
Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)
Completed
- Metastatic Breast Cancer
- OPT-822/OPT-821(30 μg/100 μg)
- +2 more
-
Birmingham, Alabama
- +42 more
Sep 14, 2020
Metastatic Breast Cancer Trial in Seoul (Everolimus(afinitor), Letrozole, Leuprolide(Lorelin Depot))
Completed
- Metastatic Breast Cancer
- Everolimus(afinitor)
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 29, 2020
Metastatic Breast Cancer Trial in Seoul (Paclitaxel, Eribulin, Gemcitabine)
Completed
- Metastatic Breast Cancer
- Paclitaxel
- +2 more
-
Seoul, Korea, Republic of
- +1 more
Jul 12, 2020
Metastatic Breast Cancer Trial in Seoul (Poziotinib)
Completed
- Metastatic Breast Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 1, 2020
Metastatic Breast Cancer Trial in Seoul (Genomic analysis)
Recruiting
- Metastatic Breast Cancer
- Genomic analysis
-
Seoul, Korea, Republic ofSamsung Medical Center, Sungkyunkwan University School of Medici
Feb 5, 2020